#Antivenom Market demand
Explore tagged Tumblr posts
Visit Tumblr Blog
Explore Tumblr blogs with no restrictions, modern design and the best experience.
Last Seen Tumblr Blogs
Fun Fact
If you dial 1-866-584-6757, you can leave an audio post for your followers.
Text
Anticipated Size of Snake Antivenom Market: $636.85M by 2032, 7.5% CAGR
Leading market research and consulting organization Polaris Market Research is excited to announce the release of its latest research report titled Snake Antivenom market. The report highlights the current state and growth potential of the Snake Antivenom market. It delves into various aspects of the market, including market share, market size, top trends, and recent developments. Also, it sheds light on the major operating strategies used by market participants to stay competitive in the market. Besides, a thorough analysis of all the major segments and sub-segments has been included in the study.
The research report includes Porter’s Five Forces analysis to examine the competitive landscape within the market. Both quantitative and qualitative analyses have been used in the study to offer an in-depth market comprehension. Also, the report makes use of pictorial representations like graphs and charts to help readers understand the key stats and other information easily. The report is a must-read for anyone looking to make strategic and informed business decisions.
Global Snake Antivenom Market size and share is currently valued at USD 332.73 million in 2023 and is anticipated to generate an estimated revenue of USD 636.85 Million by 2032, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 7.5% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2024 - 2032
Top key players: Bharat Serums and Vaccine Limited, Bioclon Institute, Boehringer-Ingelheim Thermo Fisher, Boston Scientific Corporation, BTG International Inc., CSL Limited, Hamilton Company, Incepta Vaccine Ltd., Inosan Biopharma, Merck & Co. Inc., MicroPharm, Novo Nordisk A/S, Owen Mumford Ltd., Pfizer Inc., Rare Disease Therapeutics Inc., VINS Bioproducts Limited
Market Dynamics
This section of the research study examines the key forces that affect the performance and behavior of the market. These include:
Supply and Demand: The research study examines the fluctuations in supply and demand and their impact on pricing signals.
Technological Advancements: An examination of all the major technology advancements and innovations and how they are driving market growth have been examined in the study.
Regulatory Changes: The study assesses all the major regulatory changes, policies, and initiatives and how they are influencing market demand.
Consumer Preferences: The impact of consumer behavior and preferences on Snake Antivenom market sales has been detailed in the research report.
Economic Trends: The sheds light on all the major economic trends worldwide that can affect the market dynamics.
Browse Full Insights:
Market Segmentation
This section of the research study divides the market into meaningful subgroups based on common characteristics. The Snake Antivenom market segmentation is primarily based on type, application, end-use, and region. By understanding market segmentation, businesses can create effective targeted advertising and promotions that resonate with every group. Also, it can help save time and money by avoiding mass marketing techniques that may not be effective for specific groups. Besides, businesses can collect valuable feedback from every group to improve their products/services. What’s more, segmental analysis can improve business focus by enabling them to make better decisions about location, inventory, and hiring.
Competitive Landscape
The competitive landscape examines the current state of competition in the market. It assesses all the major companies that compete with a specific company for customers. Also, it examines the options available to customers instead of the company’s products/services. Competitive landscape analysis includes several factors, including the number of competitors and their market share, product offerings, and pricing strategies. Also, it sheds light on the level of competition and major Snake Antivenom market trends. By going through the competitive landscape section, businesses can identify potential opportunities and avoid costly mistakes. Furthermore, it can assist stakeholders in capitalizing on new ideas and improving their customer journey.
Regional Analysis
Regional analysis involves the study of specific geographic regions in the Snake Antivenom market. It helps examine the impact of social, physical, and economic variables in a regional context. Also, it assists businesses in understanding consumer behavior, economic trends, and competitive landscapes. Regional analysis is important for stakeholders, businesses, analysts, and policymakers to assess the market state in various market regions and sub-regions across the globe.
The key regions and sub-regions covered in the research report are:
North America (US, Canada)
Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
The Report Answers Questions Such As:
What is the current market size and forecast market value?
What is the estimated CAGR for the market over the forecast period?
Which region is projected to witness substantial Snake Antivenom market growth?
Which segment is anticipated to lead the market?
What are the emerging business opportunities for market players?
What can strategic developments take the market in the upcoming years?
More Trending Latest Reports By Polaris Market Research:
Identity & Access Management (Iam) Market
Elderly Nutrition Market
Ferrosilicon Market
Hand Dryer Market
Aluminum Bags and Pouches Market
0 notes
Text
0 notes
Text
Snake Antivenom Market Worth US$ 1,024.7 million by 2033
New Post has been published on https://petn.ws/RhsVd
Snake Antivenom Market Worth US$ 1,024.7 million by 2033
PRESS RELEASE Published March 1, 2023 According to the Market Statsville Group (MSG), the global snake antivenom market size is expected to grow from USD 719.6 million in 2022 to USD 1,024.7 million by 2033, at a CAGR of 7.1% from 2023 to 2033. The snake antivenom market is the rising incidence of snake bites globally. This has increased demand for snake […]
See full article at https://petn.ws/RhsVd #ReptileNews
0 notes
Text
Antivenom Serum Market Analysis by Recent Developments and Demand 2022 to 2029
Antivenom Serum Market Overview
The Research report on Antivenom Serum contains all relevant information. By providing its clients with accurate data, it provides the market outlook and aids in the making of crucial decisions. The market size, share, dynamics, and forecast for major segments and sub-segments are provided in this report, which combines primary and secondary research. This market research study keeps track of all the latest advancements and changes in the industry. It gives the data regarding the obstacles while establishing the business and guides to overcome the upcoming challenges and obstacles.
Get a Sample copy of the report:
https://pharmaresearchconsulting.com/reports/antivenom-serum-market-global-growth-trends-and-forecast-2022-2029-by-type-humans-animals-by-application-monovalent-polyvalent-by-region
Get in Touch with Us: - Phone No.+1 (704) 266-3234
Mail to: [email protected]
0 notes
Text
Antivenom Market: Middle East and Africa Product Intelligence Market Analysis 2016 and Forecast to 2021
Albany/New York Pune/India, April, 2017.
Marketresearchdata.net has added a new report on Middle-East & Africa Antivenom Market. The report predicts the market size of Middle-East & Africa Antivenom Market is expected to reach XX billion by 2021.
The report covers the analysis of global as well as regional markets of Middle-East & Africa Antivenom Market. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.
Middle-East & Africa Antivenom Market Is expected to reach USD 124.2 million by 2021 from USD 89.9 million in 2016, growing at a CAGR of 6.67% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 35,000-55,000 people are recorded with snake bites annually in Africa. To overcome poisonous effects after venomous bites the manufacturers developed number of Antivenom products including vaccines and hyperimmune sera. Growing number of venomous animals bite cases, rising demand for antivenom products, emergence of new Pan-African polyvalent antivenom products using modern proteomic & antivenomic tools, and presence of antivenom financing systems are driving the growth of the Middle-East & Africa Antivenom Market. However, dearth of antivenom products, high manufacturing costs of antivenom products, decreasing antivenom production, and limited adoption of antivenom products are hampering the growth of Middle-East & Africa Antivenom Market. Middle-East & Africa Antivenom is broadly categorized into type and animal. On the basis of type, Middle-East & Africa Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snake, Scorpion, Spider, and Others. Based on geography, Middle-East & Africa Antivenom market is segmented into Middle-East and Africa. Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Vaccines
5.1.3 Hyperimmune Sera
5.1.3.1 Homologous
5.1.3.2 Heterologous
5.1.4 Y-o-Y Growth Analysis, By type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2 Animal
5.2.1 Introduction
5.2.2 Snakes
5.2.3 Scorpions
5.2.4 Spiders
5.2.5 Others
5.2.6 Y-o-Y Growth Analysis, By Animal
5.2.7 Market Attractiveness Analysis, By Animal
5.2.8 Market Share Analysis, By Animal
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.2 By Animal
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.2 By Animal
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.2 By Animal
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Instituto Bioclon, S.A. de C.V.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Pfizer AG
8.3 CSL Limited
8.4 Roche
8.5 Merck & Co
8.6 Rare Disease Therapeutics, Inc.
8.7 Vins Bioproducts Limited
8.8 BTG Plc
8.9 Incepta Vaccine Ltd
8.10 Bharat Serim and Vaccines Limited (BSV)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
To make an enquiry about report visit:
http://marketresearchdata.net/Reports/MakeEnquiryRequest/17442.html
Reasons to buy this report: 1) Deep insights and comprehensive analysis of global and regional markets 2) Complete coverage of key product types and application segments and their sub-segments through geographies and world market 3) Deep dive into the market share and recent developments of the key players in the industry. 4) Analysis and presentation of evolving market trends, patterns, technological advancements 5) Presentation of market dynamics and factors bearing control over the global and regional markets. 6) Competitive landscapes and insights 7) Opportunity mapping in terms of product developments, research and developments and technological advancements. To know more about us Visit: http://marketresearchdata.net/Welcome/About.html Reasons to choose marketresearchdata.net 1) 24X7 sales support and free analyst time for post purchase queries. 2) Exclusive support from the analysts and industry experts possessing experience over 5 years in the industry 3) Long term relationship management and exclusivity benefits for our clients To make sample request for report visit: http://marketresearchdata.net/Reports/MakeSampleRequest/17442.html Contact Us: USA/Canada Toll Free: +18006380796 Rest of the World: +919765091631 Email: [email protected] website: www.marketresearchdata.net
#Antivenom Market demand#Antivenom Market research#Antivenom Market share analysis#Antivenom Market consumption in
0 notes
Text
Global Antivenom Market Comprehensive Research Methodology, Key Insights, Segments and Extensive Profiles by 2029
Global Antivenom Market: is expected to reach US$ 1.91 Bn. at a CAGR of 8.54% during the forecast period 2029.
Global Antivenom Market Overview:
The latest study from Maximize Market Research, Global Antivenom Market 2021-2027, is helpful in understanding the market's competitors. The study takes a wide and basic look at the market, as well as a look into subjective variables that could give readers valuable business insights. The study includes a market overview that covers the value chain structure, regional analysis, applications, market size, and forecast (2021-2027). The study will be used to get a more accurate assessment of the existing and future state of the global Global Antivenom market.
Global Antivenom Market Dynamic:
The use of anti-venom is connected with various adverse reactions and so is only given to those victims who develop local, systemic, or laboratory evidence of envenoming.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.
Request for free broacher link @ https://www.maximizemarketresearch.com/request-sample/37071
Market Scope:
Throughout the projected period, the study analyses a variety of factors, including worldwide Global Antivenom market growth, consumer volume, market trends, and corporate pricing structures, in order to provide an analytical evaluation of the industry. The report provides in-depth analysis of the market's complexities. Market features, product differentiation analysis, market size, client landscape, and regional landscape are all included in the research. The report considers development direction, current trends, breakthroughs, predictions, and the competitive environment in its research. This market has been explored in a variety of categories based on profitability and industrial base.
Global Antivenom Market Segmentation:
Based on the type, the polyvalent segment is dominated by xx% during the forecast period. Polyvalent segment anti-venoms include particular antibodies that are capable of counteracting several homologous venoms from various types of genera. Polyvalent anti-venoms can save the lives of victims, even when the snake type is unknown.
The snake anti-venom segment expected to dominate the xx% market share during the forecast period. Snake anti-venoms are preparations of animal immunoglobulin used in the treatment of snakebite envenomation. The general organization for producing snake anti-venoms has undergone few changes since development the technological inventions has been presented in the manufacturing process.
Global Antivenom Market Key Players:
• Medtoxin Venom Laboratories • Institute of Immunology • Alomone Labs • Sigma Aldrich • Wyeth Pharmaceuticals • Protherics PLC • Bharat Serums and Vaccines • Butantan Institute • Haffkine Bio-Pharmaceutical Corporation Ltd • Rare Therapeutics Inc • BTG International Ltd • Micropaharm Limited • CSL Behring • Vins Bioproducts Limited • Incepta Vaccine Ltd • Allison Medical, Inc. • Artsana S.p.a. • B. Braun Melsungen AG • Becton, Dickinson and Company • Boston Scientific Corporation, • Hamilton Company • Hill-Rom • Hu-Friedy Mfg. Co., LLC • Johnson & Johnson Services, Inc
It then goes into great detail on the major rivals in the global Global Antivenom market, as well as developing companies, including revenue, demand, high-quality product producers, sales, and service providers. The study also looks at capacity utilisation, raw material sources, import-export, the value chain, pricing structure, and the industrial supply chain. This report features the following players:
Request for free Customization Link @ https://www.maximizemarketresearch.com/request-customization/37071
Regional Analysis:
Based on various types of commodities, applications, end-users, and nations, among others, the research gives detailed insights into multiple development prospects and obstacles in the above-mentioned locations. Key elements of the global Global Antivenom market, such as sales growth, product pricing and analysis, growth potential, and solutions for addressing market challenges in certain areas, are also included in the study.
COVID-19 Impact Analysis on Global Antivenom Market:
COVID-19 is a global public health emergency that has damaged almost every firm, and the long-term effects are likely to have an impact on industry growth during the projection period. Our ongoing research widens our research methods to incorporate basic COVID-19 problems as well as possible future steps. The study considers changes in consumer behaviour and demand, purchasing patterns, the dynamics of modern market forces, and significant government efforts while analysing COVID-19. The updated research includes market insights, analysis, estimates, and predictions based on COVID-19's impact.
Will You Have Any Questions About This Report? Please Contact Us On link @ https://www.maximizemarketresearch.com/inquiry-before-buying/37071
Key Questions Answered in the Global Antivenom Market Report are:
Who are the key players in the Global Antivenom industry?
In terms of the region, what is the potential market for Global Antivenom?
In the next five years, which application area of Global Antivenom is likely to develop at a substantial rate in the market?
What opportunities do new market entrants have?
How big will the Global Antivenom market be in 2027?
What are the Global Antivenom market's growth prospects?
In the Global Antivenom market report, what year is considered the base year?
In the Global Antivenom market, which region has the biggest market share?
What elements do you think will drive the Global Antivenom market?
About Maximize Market Research: Maximize Market Research, a global market research firm with a dedicated team of professionals and data has carried out extensive research on the Transportation management system market. Maximize Market Research provides syndicated and custom B2B and B2C business and market research on 12,000 high-growth emerging technologies, opportunities, and threats to companies in the chemical, healthcare, pharmaceuticals, electronics, and communications, internet of things, food and beverage, aerospace and defense, and other manufacturing sectors. Maximize Market Research is well-positioned to analyze and forecast market size while also taking into consideration the competitive landscape of the sectors. Contact Us: MAXIMIZE MARKET RESEARCH PVT. LTD. 3rd Floor, Navale IT Park Phase 2, Pune Banglore Highway, Narhe, Pune, Maharashtra 411041, India. Email: [email protected] Phone No.: +91 20 6630 3320 Website: www.maximizemarketresearch.com
0 notes
Link
“Anti-Venom Market ”gives detailed outlook by Type, by Application, by Segmentation and Regional Forecasts.
0 notes
Text
Anti-Venom Market to Booming $729.9 Mn, Globally by 2026 at a 4.7% CAGR : Coherent Market Insights
Anti-venom, sometimes called anti-venomine, anti-venom, and venom antidote, is a medical remedy for envenoming. It consists of antibodies specifically produced to counter-venoms caused by insects. Antivenoms are generally recommended only in cases of severe poisoning or if there is a high probability of serious toxicity. People allergic to poison ivy, trypanosporiasis, bee stings, and other potentially hazardous plants are not recommended to take anti-venoms. An allergy to bee stings can cause anaphylactic shock, which results in symptoms such as nausea, difficulty breathing, and swelling of the face and throat. People can have an acute allergic reaction when they are exposed to snakes that secrete venom in their saliva.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1249
Competitive Landscape
Major companies contributing to the global anti-venom market include Bharat Serums and Vaccines Limited, Merck & Co., Inc., CSL Limited, Laboratorios Silanes, BTG plc., Rare Disease Therapeutics, Incepta Pharmaceuticals Ltd., Pfizer, Inc., Vins Bioproducts Limited, and Haffkine Bio-Pharmaceutical Corporation Ltd.
Drivers
Elevated fatality rates as a result of snakebites coupled with growing occurrences of envenomation-driven symptoms are expected to augment growth of the anti-venom market during the forecast period.
In addition to this, increasing expenditure on the development of anti-venoms as a potential cure for paralysis and other medical conditions is expected to aid growth of the anti-venom market throughout the forecast period.
The Epitome of the COVID-19 Aftermath
The global anti-venom market has shown a decent sign of upswing during the prevalence of the COVID-19 virus. The rural areas have witnessed a steep rise in the envenoming cases. Coupled with this, rural places have also seen homecoming of working population from the urban space amidst adoption of the remote-work model.
Buy This Complete Business Report @: https://www.coherentmarketinsights.com/insight/buy-now/1249
Key Takeaways
• The anti-venom market is anticipated to grow at a CAGR of XX % throughout the forecast period on the heels of rising incidences of snakebites and growing government support. For instance, in May 2021, the World Health Organization (WHO) reported that around 2.7 million individuals suffer from envenoming and its resultant symptoms.
• On the geographical front, the Asia Pacific region is a treasure island for the global anti-venom market at the helm of a large envenom caseload (nearly 2 million annually as per WHO) and growing demand from wildlife sanctuaries.
• Bubbling under the top spot, the African region is another hot favorite for the global anti-venom market in the view of a vast rural area and the presence of several venomous snake species.
0 notes
Text
0 notes
Text
Antivenom Serum Market Global Demand and Forecast by 2027: Standard Version Of Report
Antivenom Serum Market Global Demand and Forecast by 2027: Standard Version Of Report
Outlook and prospects of Antivenom Serum market assess the market loudness in addition to factors that influence the growth. It introduces a booming company perspective of this global Antivenom Serum market together with the overview of top market players. It also forecast its growth within the coming years with Antivenom Serum statistics and analytics accounted for relatively optimistic…
View On WordPress
0 notes
Text
Anti-Venom Market 2020- Analysis and Trends
Anti-Venom Market Driven by Enhancing Regulatory Framework
The recent report by Market Research Future (MRFR) predicts the global anti-venom market value will be expanding with a healthy CAGR of 6.5% over the forecast period (2017–2023).
Biotechnology, as well as the healthcare industry, is noting a considerable demand from developing nations globally. The prominent reason behind the strong growth of the anti-venom market is the growing demand for anti-venom treatment, as it is the only authorized treatment for snake bite, without any alternative treatment available. Moreover, violation of forest lands for housing and agricultural needs has gotten humans close to poisonous animals and insects, thereby increasing the prevalence of venomous bites. In addition, the prevalence of snake bites, scorpion bites, as well as other animal or insect bites like fish stings is an additional factor playing a major role in the anti-venom market growth.
Various research and development (R&D) activities taking place continuously that provide advanced drugs and standard treatment for poisonous insect bite further uplifts the market position of anti-venom. Growing demand for anti-venoms in the emerging countries is encouraging the prominent players to penetrate these markets, such as in India and Africa in order to offer anti-venom products at a cost-effective price. This is yet another driver responsible for the growth of the global anti-venoms market.
In contrast, the high cost of anti-venom due to the high production cost in a few regions could hamper the growth of the anti-venom market. However, the rapid development of the economic conditions around the world is creating massive opportunities for the expansion of the anti-venom market. The improving economy is increasing the individual per capita income, which will increase the spending capacity on health care. The contribution of the developing countries of Asia Pacific as well as the Middle East coupled with the growing population and increasing capita income will foster the growth of the market.
Segmentation
The global anti-venom market is segmented on the basis of type, type of species, mode of action, product type, and end user.
The global anti-venom market, by type, is categorized into polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.
By species type, the global anti-venom market is segmented into snakes, scorpions, spiders, and others. The snake segment is further classified as a common cobra, common krait, Russell Viper, and others.
Based on the mode of action, the global anti-venom market is divided into cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.
The product types in the global anti-venom market include snake anti-venom, scorpion anti-venom, spider anti-venom, and others.
End-user-wise, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.
Regional Analysis
The regions among which the global anti-venom market is segmented into are Asia Pacific, Europe, Americas, and the Middle East and Africa.
At a global level, the Americas will be leading the anti-venom market in the coming years on account of the increasing cases of snake bites, as well as scorpion bites coupled with the high healthcare expenditure.
Europe will be securing the second position in the global anti-venom market, due to the strong financial support by the government for research and development along with the improvement in reimbursement scenario, driving the Europe anti-venom market. As per the data furnished by Eurostat, it is noted that among all the EU Member States, the highest value of healthcare expenditure has been recorded in Germany in the year 2014, which was around EUR 321 billion, followed by France at the value of EUR 237 billion and United Kingdom valued at EUR 223 billion. In the year 2016, the R&D expenditure for the pharmaceutical industry was at the value of EUR 35000 million, stated by the European Federation of Pharmaceutical Industries and Association.
Furthermore, Asia Pacific is touted to be the fastest growing anti-venom market, resulting from the massive patient pool coupled with the increasing advancements in pharmaceuticals. As per the Indian Brand Equity Foundation (IBEF), the generics market in the country was around USD 26.1 billion in the year 2016. Moreover, according to the statistics by the World Health Organization (WHO), around 2.8 million people are bitten by snakes, and close to 46 900 people succumb to snakebites every year.
Lastly, the market in the Middle East and Africa account for the lowest share of the global market owing to the restricted economic development, lack of technical knowhow, and poor medical facilities.
Competitive Landscape
Thermo Fisher Scientific, Ypsomed Holding AG, Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Allison Medical, Inc., cHill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Allison Medical, Inc., Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Novo Nordisk A/s, UltiMed, Inc., Boston Scientific Corporation, are some of the leading companies in the global anti-venom market.
Industry Update
February 2019 – Kenya’s Ministry of Health is set to produce anti-snake venom for ensuring a sustainable supply, in addition to developing few policies, guidelines as well as processes for identifying cheaper high-quality brands for licensing. The products will be procured and distributed to public health facilities by the country’s medical supplies authority.
Read More @https://www.marketresearchfuture.com/reports/anti-venom-market-5859
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India +1 646 845 9312 Email: [email protected]
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
0 notes
Text
Anti-Venom Market 2020: Global Industry Analysis Report To 2025
Global Anti-Venom Market Research Report 2020 recently published on Empirical Data Insights is a key document abstract for industries/clients to understand current global competitive market status. The Anti-Venom market study report base year is 2019 and provides market research data status (2015-2020) and forecast (2020-2025) and also further categorizes the Anti-Venom Market into key industries, region, type, and application. Global Anti-Venom Market study report covers all major geographical regions and sub-regions in the world and concentrates on product sales, value, market size, and growth opportunities in these regions.
For more information, Get sample pdf @ http://www.empiricaldatainsights.com/sample-request/3564
The report provides information about Anti-Venom Market Landscape. Classification and types of Anti-Venom are analyzed in the report and then Anti-Venom market analyzed by application and end users. Market analysis is sourced from historical data on current trends and situation within the market. It also provides insights on future opportunities within the forecast for years 2020-2025.
Major Market Players Covered In This Report:
CSL Behring, Merck & Co. BTG Plc, Pfizer, Haffkine Bio-Pharmaceutical Corporation, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech
Check Discount @ http://www.empiricaldatainsights.com/discount-request/3564
According to the report, product expense of the Anti-Venom market is segmented into:
Polyvalent Antivenom, Monovalent Antivenom
Apart from that the application market is segmented into:
Retail Pharmacies, Hospitals, Others
Some key points of Anti-Venom Market research report:
Business description: A detailed Overview of the Anti-Venom Industry.
Industry Outlook: The Anti-Venom Market report offers product overview, market share, supply chain analysis, demand and supply ratio, and import/export details.
Key Competitors: Anti-Venom Market leading players are studied with respect to their company profile, product portfolio, capacity, price, cost and revenue.
Major Products: Anti-Venom brands, services, and products of the company.
Market Dynamics: Readers are provided with competitive analysis of market challenges, influence factors, drivers, opportunities, growth, and trends.
Readability: Anti-Venom market report compiles graphical representation of data in the form of tables, graphs, and pie-charts that makes the report highly readable, and easy to understand.
Expert Analysis: Sales revenue, Future Strategies, Innovation and Technological trends, factors impacting development, and SWOT.
Customization of the Report: This report can be customized as per your needs for additional data or countries. Please connect with our sales team ([email protected])
0 notes
Link
0 notes
Text
Asia-Pacific of Antivenom Market Market Sales Market Research Report Overview, Analysis Research Report 2021
Albany/New York Pune/India, April, 2017.
Marketresearchdata.net has added a new report on Asia-Pacific Antivenom Market. The report predicts the market size of Asia-Pacific Antivenom Market is expected to reach XX billion by 2021.
The report covers the analysis of global as well as regional markets of Asia-Pacific Antivenom Market. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.
Asia-Pacific Antivenom Market is expected to reach USD 325.7 million by 2021 from USD 215.7 million in 2016, growing at a CAGR of 8.59% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 40,000-80,000 people die in Asia (Majorly from India) with snake bites annually. To overcome poisonous effects after venomous bites the manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.
Browse Full Report visit:
http://marketresearchdata.net/Reports/asia-pacific-antivenom-market Rising demand for antivenom products, growing number of snake bite cases as compared to developed regions, development of effective antivenom products against more number of snake species, and increasing number of manufacturers to focus on antivenom products in the Asia region (especially in India) are driving the growth of Asia-Pacific Antivenom Market. However, dearth of antivenom products, high cost of the products, existence of new regulations, requirement of training to medical staffs, and presence of underdeveloped medical infrastructure are restraining the growth of the Asia-Pacific Antivenom Market. Asia-Pacific Market for Antivenom is broadly categorized into type and animal. On the basis of type, Asia-Pacific Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others. Geographically, Asia-Pacific Antivenom market is segmented into China, India, Japan, South Korea, and Australia. Asia-Pacific is the fastest growing region with a CAGR of 8.59% during the forecast period 2016-2021. Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).
Table of Content
1. Introduction 1.1 Market Definition 1.2 Study Deliverables 1.3 Base Currency, Base Year and Forecast Periods 1.4 General Study Assumptions 2. Research Methodology 2.1 Introduction 2.2 Research Phases 2.2.1 Secondary Research 2.2.2 Primary Research 2.2.3 Econometric Modelling 2.2.4 Expert Validation 2.3 Analysis Design 2.4 Study Timeline 3. Overview 3.1 Executive Summary 3.2 Key Inferences 3.3 Epidemology 4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 4.1 Market Drivers 4.2 Market Restraints 4.3 Key Challenges 4.4 Current Opportunities in the Market 5. Market Segmentation 5.1 Type 5.1.1 Introduction 5.1.2 Vaccines 5.1.3 Hyperimmune Sera 5.1.3.1 Homologous 5.1.3.2 Heterologous 5.1.4 Y-o-Y Growth Analysis, By type 5.1.5 Market Attractiveness Analysis, By Type 5.1.6 Market Share Analysis, By Type 5.2 Animal 5.2.1 Introduction 5.2.2 Snakes 5.2.3 Scorpions 5.2.4 Spiders 5.2.5 Others 5.2.6 Y-o-Y Growth Analysis, By Animal 5.2.7 Market Attractiveness Analysis, By Animal 5.2.8 Market Share Analysis, By Animal 6. Geographical Analysis 6.1 Introduction 6.1.1 Regional Trends 6.1.2 Impact Analysis 6.1.3 Y-o-Y Growth Analysis 6.1.3.1 By Geographical Area 6.1.3.2 By Type 6.1.3.2 By Animal 6.1.4 Market Attractiveness Analysis 6.1.4.1 By Geographical Area 6.1.4.2 By Type 6.1.4.2 By Animal 6.1.5 Market Share Analysis 6.1.5.1 By Geographical Area 6.1.5.2 By Type 6.1.5.2 By Animal 6.2 China 6.3 India 6.4 Japan 6.5 South Korea 6.6 Australia 7.Strategic Analysis 7.1 PESTLE analysis 7.1.1 Political 7.1.2 Economic 7.1.3 Social 7.1.4 Technological 7.1.5 Legal 7.1.6 Environmental 7.2 Porter’s Five analysis 7.2.1 Bargaining Power of Suppliers 7.2.2 Bargaining Power of Consumers 7.2.3 Threat of New Entrants 7.2.4 Threat of Substitute Products and Services 7.2.5 Competitive Rivalry within the Industry 8.Market Leaders' Analysis 8.1 Instituto Bioclon, S.A. de C.V. 8.1.1 Overview 8.1.2 Product Analysis 8.1.3 Financial analysis 8.1.4 Recent Developments 8.1.5 SWOT analysis 8.1.6 Analyst View 8.2 Pfizer AG 8.3 CSL Limited 8.4 Roche 8.5 Merck & Co 8.6 Rare Disease Therapeutics, Inc. 8.7 Vins Bioproducts Limited 8.8 BTG Plc 8.9 Incepta Vaccine Ltd 8.10 Bharat Serim and Vaccines Limited (BSV) 9.Competitive Landscape 9.1 Market share analysis 9.2 Merger and Acquisition Analysis 9.3 Agreements, collaborations and Joint Ventures 9.4 New Product Launches 10.Market Outlook and Investment Opportunities Appendix a) List of Tables b) List of Figures
To make an enquiry about report visit:
http://marketresearchdata.net/Reports/MakeEnquiryRequest/17440.html
Reasons to buy this report: 1) Deep insights and comprehensive analysis of global and regional markets 2) complete coverage of key product types and application segments and their sub-segments through geographies and world market 3) Deep dive into the market share and recent developments of the key players in the industry. 4) Analysis and presentation of evolving market trends, patterns, technological advancements 5) Presentation of market dynamics and factors bearing control over the global and regional markets. 6) Competitive landscapes and insights 7) Opportunity mapping in terms of product developments, research and developments and technological advancements. To know more about us Visit: http://marketresearchdata.net/Welcome/About.html Reasons to choose marketresearchdata.net 1) 24X7 sales support and free analyst time for post purchase queries. 2) Exclusive support from the analysts and industry experts possessing experience over 5 years in the industry 3) Long term relationship management and exclusivity benefits for our clients
To make sample request for report visit: http://marketresearchdata.net/Reports/MakeSampleRequest/17440.html Contact Us: USA/Canada Toll Free: +18006380796 Rest of the World: +919765091631 Email: [email protected] website: www.marketresearchdata.net
#Antivenom Market Market straight#Antivenom Market Market demand#Antivenom Market Market research#Antivenom Market Market application
0 notes
Link
0 notes
Text
Antivenoms Market 2018 Industry Price Trend, Size Estimation, Industry Outlook, Business Growth, Report Latest Research, Business Analysis and Forecast 2023 Analysis Research | 360 Market Updates
Antivenoms Market (2018 – 2023) report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The Antivenoms market report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
“Antivenoms Market report is anticipated to register a CAGR of 4.4% over a five years forecast period (2018 – 2023).”
Get a Sample PDF of Report @ https://www.360marketupdates.com/enquiry/request-sample/12883601
List of Major Key players operating in the Global Antivenoms Market are –
PFIZER INC
BIOCLON INSTITUTE
CSL LIMITED
BTG PLC
MERCK AND CO.
SIGMA ALDRICH
MICROPHARM
BOEHRINGER-INGELHEIM
The global antivenoms market has been estimated to reach USD 152.31 million in 2017.The market is expected to register a CAGR of 4.4% during the forecast period 2018 to 2023. North America is dominating the market due to increasing antivenom products and research & development for effective antivenom products in that region. Increasing Awareness on Antivenoms Available Snake bite is a neglected public health issue in many tropical and subtropical countries. About 5 million snake bites occur each year, resulting in up to 2.5 million envenoming’s (poisoning from snake bites), at least 100 000 deaths and around three times as many amputations and other permanent disabilities. But due to the involvement of international health organizations for producing safe and effective antivenoms people are aware about such antivenoms drugs. Additionally, recent advancement in pharmaceuticals is also fuelling the global antivenom market. High Cost of Available Antivenoms Antivenom production is difficult and expensive. The cost of some antivenom has increased dramatically over the last two decades, making treatment unaffordable for most of the people who need it. Increasing prices have suppressed demand and the treatment has declined significantly, or disappeared entirely in some areas. Inappropriate procurement and medicine distribution strategies in few countries contribute to manufacturers ceasing the production of antivenom or increasing the prices of antivenom. The high cost of the drug, which is around USD 540 per four vial treatment is an example to say that the product never reached many people who cannot afford the treatment. Also, preparation of the correct immunogens (snake venoms), lack of regulatory capacity for the control of antivenoms in countries, and weak health systems and lack of data are acting restraints the Global Antivenom market. North America to Dominate the Market The Global Antivenom Market is segmented into by animals (snakes, scorpion, spiders and others), by type of antivenoms (polyvalent heterologous, monovalent heterologous, homologous and small molecule anti-toxins) and geography. . By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America contributes a major share in antivenom market due to the establishment of snake poison control centers, increase in antivenom products and rise in clinical trial conducting firms for antivenom products and established healthcare facilities in that region.
Share your query before purchasing this report @ https://www.360marketupdates.com/enquiry/pre-order-enquiry/12883601
Scope of the Report:
The report analyses Antivenoms market, which includes –
Analysis of the growth of Antivenoms market in global and regional level including Asia-Pacific, Americas, and EMEA.
The report provides Antivenoms market analysis for key countries including the US, Canada, Chile, China, India, Japan, the UK, Germany, France, and Italy.
The report offers country level Antivenoms market volume and value by end-user segment for the period 2012-2023.
Qualitative analysis of key market drivers and restraints, and analysis of their impacts on Antivenoms market are discussed.
The report provides competitive landscape at country level for the year 2018. It also covers key policies and initiatives, key deals, and key upcoming projects.
Highlighted points of Antivenoms Market Report:
Varying dynamics of the Antivenoms industry.
Prospective changes in sales volumes and worldwide share growth in upcoming years (2018-2023).
Antivenoms market report recognizes the key drivers of growth and challenges of the key industry players.
Competitors profiles along with product description, overview, and business data.
A complete analysis of market risks, opportunities, limitations, and growth of the market.
Market driving and restraining factors.
Delivers information on the historical and current market size and the future potential of the market.
Antivenoms market report provides a comprehensive analysis of the market with respect to market dynamics, competitive analysis, and upcoming trends of the market.
Purchase this report (Price 4250 USD for a single-user license) @ https://www.360marketupdates.com/purchase/12883601
Reasons to Purchase Antivenoms Market Report:
The report analyses how stringent emission control norms will drive the global Antivenoms market.
Analyzing various perspectives of the market with the help of Porter’s five forces analysis.
Study on the product type that is expected to dominate the market.
Study on the regions that are expected to witness the fastest growth during the forecast period.
Identify the latest developments, market shares and strategies employed by the major Antivenoms market players.
3 months’ analyst support along with the Market Estimate sheet (in excel).
In this study, the years considered to estimate the market size of Antivenoms:
History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2023
Look into Table of Content of Antivenoms Market Report @ https://www.360marketupdates.com/TOC/12883601#TOC
Contact Info: -
360 Market Updates
Mr. Ajay More
USA: +1 424 253 0807
UK: +44 203 239 8187
0 notes